Emergent BioSolutions Inc. financial data

Symbol
EBS on NYSE
Industry
Pharmaceutical Preparations
Location
300 Professional Dr, Gaithersburg, MD
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
Nov 7, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 126 % +21.6%
Quick Ratio 61.1 % +62.8%
Debt-to-equity 200 % +42.7%
Return On Assets -12.6 % +58.7%
Operating Margin -12.7 % +81%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 54.2M shares
Common Stock, Shares, Outstanding 54.1M shares +4.44%
Entity Public Float 381M USD -74.6%
Common Stock, Value, Issued 100K USD 0%
Weighted Average Number of Shares Outstanding, Basic 53.1M shares +2.51%
Weighted Average Number of Shares Outstanding, Diluted 55.6M shares +7.34%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 1.13B USD +2.05%
Research and Development Expense 91M USD -31%
Operating Income (Loss) -143M USD +80.6%
Nonoperating Income (Expense) -26.8M USD -13300%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -170M USD +77.1%
Income Tax Expense (Benefit) 39M USD +16.4%
Net Income (Loss) Attributable to Parent -209M USD +73.2%
Earnings Per Share, Basic -3.95 USD/shares +74.2%
Earnings Per Share, Diluted -4.05 USD/shares +73.5%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 150M USD +70.7%
Accounts Receivable, after Allowance for Credit Loss, Current 121M USD -44%
Inventory, Net 323M USD -8.87%
Assets, Current 661M USD -8.24%
Property, Plant and Equipment, Net 278M USD -29.7%
Operating Lease, Right-of-Use Asset 12.4M USD -27.5%
Intangible Assets, Net (Excluding Goodwill) 518M USD -11.2%
Goodwill 0 USD
Other Assets, Noncurrent 20.5M USD -89.4%
Assets 1.48B USD -21.9%
Accounts Payable, Current 82.1M USD -27.2%
Employee-related Liabilities, Current 63.3M USD -23.3%
Accrued Liabilities, Current 16.1M USD -5.29%
Contract with Customer, Liability, Current 7.3M USD -68.1%
Liabilities, Current 230M USD -65.4%
Contract with Customer, Liability, Noncurrent 5.9M USD -88.8%
Deferred Income Tax Liabilities, Net 41.9M USD -20%
Operating Lease, Liability, Noncurrent 10.7M USD -26.7%
Other Liabilities, Noncurrent 35.8M USD +14.4%
Liabilities 969M USD -18.9%
Accumulated Other Comprehensive Income (Loss), Net of Tax -7.3M USD -181%
Retained Earnings (Accumulated Deficit) -181M USD -754%
Stockholders' Equity Attributable to Parent 508M USD -27.1%
Liabilities and Equity 1.48B USD -21.9%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -62.6M USD +66%
Net Cash Provided by (Used in) Financing Activities 40.7M USD
Net Cash Provided by (Used in) Investing Activities -10.8M USD +28.5%
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Shares, Issued 59.7M shares +4.01%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -32.7M USD +84.4%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 156M USD +78.1%
Interest Paid, Excluding Capitalized Interest, Operating Activities 21.5M USD -0.46%
Deferred Tax Assets, Valuation Allowance 258M USD +296%
Deferred Tax Assets, Gross 270M USD +106%
Operating Lease, Liability 13.4M USD -26%
Depreciation 47.4M USD -26.1%
Payments to Acquire Property, Plant, and Equipment 10.8M USD -28.5%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -214M USD +72.4%
Lessee, Operating Lease, Liability, to be Paid 20.4M USD -13.2%
Property, Plant and Equipment, Gross 672M USD -15.6%
Operating Lease, Liability, Current 2.7M USD -22.9%
Lessee, Operating Lease, Liability, to be Paid, Year Two 3.7M USD -14%
Lessee, Operating Lease, Liability, to be Paid, Year One 4.3M USD -33.8%
Operating Lease, Weighted Average Discount Rate, Percent 0.06 pure 0%
Deferred Income Tax Expense (Benefit) 1.9M USD
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 3.1M USD +6.9%
Lessee, Operating Lease, Liability, to be Paid, Year Three 2.9M USD +7.41%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 15M shares 0%
Unrecognized Tax Benefits 6.6M USD -2.94%
Lessee, Operating Lease, Liability, to be Paid, Year Four 2.3M USD 0%
Additional Paid in Capital 924M USD +2.75%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 65M USD -3.42%
Depreciation, Depletion and Amortization 27.9M USD -19.4%
Deferred Tax Assets, Net of Valuation Allowance 11.7M USD -82.2%
Share-based Payment Arrangement, Expense 17.7M USD -42.5%
Interest Expense 94.3M USD +101%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%